169 related articles for article (PubMed ID: 19695959)
1. Differential dynamics of donor DC and non-DC peripheral blood mononuclear cell microchimerism in lung transplantation.
Van der Meulen J; Mifsud NA; Abud D; Paul E; Varney MD; Lewin SR; Cameron PU; Kotsimbos TC
Clin Immunol; 2009 Nov; 133(2):179-83. PubMed ID: 19695959
[TBL] [Abstract][Full Text] [Related]
2. Chimerism of dendritic cell subsets in peripheral blood after lung transplantation.
Paantjens AW; van de Graaf EA; Heerkens HD; Kwakkel-van Erp JM; Hoefnagel T; van Kessel DA; van den Bosch JM; Otten HG
J Heart Lung Transplant; 2011 Jun; 30(6):691-7. PubMed ID: 21388830
[TBL] [Abstract][Full Text] [Related]
3. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic microchimerism and donor antigen-specific hyporeactivity in lung transplant recipients.
McSherry C; Hertz MI; Jackson AM; Butters K; Diko M; Matas AJ; Bolman RM; Reinsmoen NL
Clin Transplant; 1995 Dec; 9(6):442-9. PubMed ID: 8645886
[TBL] [Abstract][Full Text] [Related]
5. Amount of co-transplanted donor-derived leukocytes determines in-vivo microchimerism and mixed lymphocyte culture changes post-liver transplantation.
Weber S; Salguero R; Allers C; Blaheta RA; Markus BH
Zentralbl Chir; 2003 Apr; 128(4):278-82. PubMed ID: 12700983
[TBL] [Abstract][Full Text] [Related]
6. Correlation of donor leukocyte chimerism with pulmonary allograft survival after immunosuppressive drug withdrawal in a porcine model.
Kruse B; Thissen S; Warnecke G; Avsar M; Gottlieb J; Hohlfeld JM; Karstens JH; Kaever V; Länger F; Pabst B; Ungefroren H; Haverich A; Strüber M
Transplantation; 2009 May; 87(10):1468-77. PubMed ID: 19461483
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of donor chimerism and tolerance after human liver transplantation.
Ayala R; Grande S; Albizua E; Crooke A; Meneu JC; Moreno A; Pérez B; Gilsanz F; Moreno E; Martínez-Lopez J
Liver Transpl; 2009 Jun; 15(6):581-91. PubMed ID: 19479801
[TBL] [Abstract][Full Text] [Related]
8. Prospective analysis between the therapy of immunosuppressive medication and allogeneic microchimerism after liver transplantation.
Araújo MB; Leonardi LS; Leonardi MI; Boin IF; Magna LA; Donadi EA; Kraemer MH
Transpl Immunol; 2009 Jan; 20(3):195-8. PubMed ID: 18790055
[TBL] [Abstract][Full Text] [Related]
9. Infusion of donor hepatic non-parenchymal cells prolongs survival of skin allografts in mice: role of microchimerism and IL-4.
Ding XM; Xue WJ; Ji ZZ; Tian PX
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):34-7. PubMed ID: 17287163
[TBL] [Abstract][Full Text] [Related]
10. The cryopreservation of high concentrated PBMC for dendritic cell (DC)-based cancer immunotherapy.
Heo YJ; Son CH; Chung JS; Park YS; Son JH
Cryobiology; 2009 Apr; 58(2):203-9. PubMed ID: 19152796
[TBL] [Abstract][Full Text] [Related]
11. [Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival].
Su G; Zhao WZ; Chen JJ; Xu J; Qiao CH; Liu C; Sun ZQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1562-7. PubMed ID: 18819868
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of organs is transplantations of donor DNA: fate of DNA disseminated in recipient.
Olszewski WL; Interewicz B; Maksymowicz M; Stanislawska J
Transpl Int; 2005 Apr; 18(4):412-8. PubMed ID: 15773960
[TBL] [Abstract][Full Text] [Related]
13. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study.
Lapierre V; Aupérin A; Robinet E; Ferrand C; Oubouzar N; Tramalloni D; Saas P; Debaene B; Lasser P; Tiberghien P
Transfusion; 2007 Sep; 47(9):1691-9. PubMed ID: 17725736
[TBL] [Abstract][Full Text] [Related]
14. Human leucocyte antigen-defined microchimerism early post-transplant does not predict for stable lung allograft function.
Rowntree LC; Bayliss J; Nguyen TH; Kotsimbos TC; Mifsud NA
Clin Exp Immunol; 2013 Jun; 172(3):483-9. PubMed ID: 23600837
[TBL] [Abstract][Full Text] [Related]
15. Mixed chimerism in SCT: conflict or peaceful coexistence?
Liesveld JL; Rothberg PG
Bone Marrow Transplant; 2008 Sep; 42(5):297-310. PubMed ID: 18660844
[TBL] [Abstract][Full Text] [Related]
16. An in vitro evaluation of the potential suitability of peripheral blood CD14(+) and bone marrow CD34(+)-derived dendritic cells for a tolerance inducing regimen in the primate.
Ashton-Chess J; Blancho G
J Immunol Methods; 2005 Feb; 297(1-2):237-52. PubMed ID: 15777946
[TBL] [Abstract][Full Text] [Related]
17. Donor type microchimerism is an infrequent event following liver transplantation and is not associated with graft acceptance.
Norris S; Lawler M; McCann S; Hegarty J; O'Farrelly C
Hepatology; 1997 Oct; 26(4):848-52. PubMed ID: 9328303
[TBL] [Abstract][Full Text] [Related]
18. Should microchimerism turn into rejection prophylactics?
Pujal JM
Expert Rev Mol Diagn; 2010 Jan; 10(1):107-18. PubMed ID: 20014925
[TBL] [Abstract][Full Text] [Related]
19. PCR-based methodology for molecular microchimerism detection and quantification.
Pujal JM; Gallardo D
Exp Biol Med (Maywood); 2008 Sep; 233(9):1161-70. PubMed ID: 18535170
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms associated with donor-specific microchimerism in peripheral blood of Brazilian patients after liver transplantation.
Araújo MB; Leonardi LS; Boin IF; Leonardi MI; Meirelles L; Magna LA; Donadi EA; Kraemer MH
Transplant Proc; 2006 Jun; 38(5):1411-7. PubMed ID: 16797319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
